Heron Therapeautics Inc (HRTX)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -168.651 | -130.876 | -51.355 | -42.001 | -52.469 | -66.948 | -66.437 | -46.703 |
Return on Equity (%) | -357.516 | -359.438 | -71.351 | -52.907 | -70.988 | -140.535 | -405.769 | 1083.859 |
Return on Invested Capital (%) | -233.25 | -244.176 | -73.46 | -54.485 | -71.342 | -97.883 | -99.724 | -79.352 |
Operating Margin (%) | -13329.085 | -629.073 | -227.39 | -139.261 | -254.267 | -252.789 | -169.44 | -83.98 |
Net Profit Margin (%) | -13537.373 | -641.87 | -230.839 | -140.27 | -256.411 | -255.58 | -171.737 | -87.024 |
Book Value Per Share | -0.54 | 2.03 | 4.735 | 4.472 | 2.59 | 0.76 | 0.114 | -0.226 |
Earnings Per Share | -4.4 | -3.057 | -2.288 | -2.267 | -2.489 | -2.163 | -1.552 | -0.737 |
Cash Per Share | 0.341 | 2.238 | 0.407 | 0.796 | 1.151 | 0.888 | 0.129 | 0.191 |
Working Capital Per Share | 0.595 | 1.933 | 4.544 | 4.234 | 2.318 | 1.798 | 1.033 | 0.727 |
Operating Profit Per Share | 0.032 | 0.429 | 0.658 | 0.957 | 0.606 | 0.425 | 0.443 | 0.432 |
EBIT Per Share | -4.4 | -3.057 | -2.288 | -2.267 | -2.489 | -2.163 | -1.552 | -0.737 |
EBITDA Per Share | -4.4 | -3.057 | -2.288 | -2.267 | -2.489 | -2.163 | -1.552 | -0.737 |
Free Cash Flow Per Share | -4.348 | -3.041 | -2.19 | -2.211 | -2.446 | -2.163 | -1.561 | -0.746 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 39,36M | 64,61M | 78,17M | 90,3M | 91,31M | 102,01M | 119,16M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 119,16M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -110.647 | N/A | N/A | N/A | -9.115 | N/A | N/A |
Net Profit Margin (%) | N/A | -110.647 | N/A | N/A | N/A | -9.115 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 243,35M |
Ratio cours/bénéfice | -2,12 |
Ratio prix/ventes | 1,84 |
Ratio prix/liquidités | 8,17 |
Ratio prix/valeur comptable | -6,89 |
Rendement de dividende | - |
Actions en circulation | 152,09M |
Volume moyen (1 semaine) | 1,62M |
Volume moyen (1 mois) | 6,39M |
Variation sur 52 semaines | -12,36% |
Plus haut sur 52 semaines | 3,93 |
Plus bas sur 52 semaines | 1,04 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales